150 related articles for article (PubMed ID: 20443518)
1. A double-blind clinical safety study of noni fruit juice.
West BJ; White LD; Jensen CJ; Palu AK
Pac Health Dialog; 2009 Nov; 15(2):21-32. PubMed ID: 20443518
[TBL] [Abstract][Full Text] [Related]
2. Morinda citrifolia (Noni) fruit--phytochemistry, pharmacology, safety.
Potterat O; Hamburger M
Planta Med; 2007 Mar; 73(3):191-9. PubMed ID: 17286240
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
4. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
5. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
Vaughan D; Speed J; Medve R; Andrews JS
Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
[TBL] [Abstract][Full Text] [Related]
6. Xanthine oxidase inhibiting effects of noni (Morinda citrifolia) fruit juice.
Palu A; Deng S; West B; Jensen J
Phytother Res; 2009 Dec; 23(12):1790-1. PubMed ID: 19434757
[TBL] [Abstract][Full Text] [Related]
7. Delayed ossification in Wistar rats induced by Morinda citrifolia L. exposure during pregnancy.
Marques NF; Marques AP; Iwano AL; Golin M; De-Carvalho RR; Paumgartten FJ; Dalsenter PR
J Ethnopharmacol; 2010 Mar; 128(1):85-91. PubMed ID: 20038450
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the ergogenic potential of noni juice.
Ma DL; West BJ; Su CX; Gao JH; Liu TZ; Liu YW
Phytother Res; 2007 Nov; 21(11):1100-1. PubMed ID: 17604369
[TBL] [Abstract][Full Text] [Related]
9. Failure of juice or juice extract from the noni plant (Morinda citrifolia) to protect rats against oxygen toxicity.
Berg JT; Furusawa E
Hawaii Med J; 2007 Feb; 66(2):41-4. PubMed ID: 17393917
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
11. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Promethazine Hydrochloride (CAS No. 58-33-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Dec; 425():1-272. PubMed ID: 12616286
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
15. The effects of Morinda citrifolia L. (noni) on the immune system: its molecular mechanisms of action.
Palu AK; Kim AH; West BJ; Deng S; Jensen J; White L
J Ethnopharmacol; 2008 Feb; 115(3):502-6. PubMed ID: 18063495
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, parallel-group, placebo-controlled trial of Extract Sceletium tortuosum (Zembrin) in healthy adults.
Nell H; Siebert M; Chellan P; Gericke N
J Altern Complement Med; 2013 Nov; 19(11):898-904. PubMed ID: 23441963
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
